mycoplasma pneumonia


mycoplasma pneumonia

A primary atypical pneumonia caused by Mycoplasma pneumoniae, which is associated with mini-epidemics that spread by aerosol or close contact to most individuals in closed populations (e.g., military boot camps, boarding schools, colleges), affecting those aged 5–20.
 
Clinical findings
Incubation ± 3 weeks; insidious onset of fever, malaise, headache, myalgia, low-grade fever, cough, chest pain and respiratory disease, from asymptomatic to rhinitis, pharyngitis, tracheobronchitis and pneumonia.
Lab
Leukocytosis, relative increase in PMNs, cold hemagglutinins, biologic false-positive VDRL.
 
Complications
Erythema multiforme, Raynaud’s disease, cold agglutinin haemolysis; less commonly, neurological, cardiovascular, musculoskeletal defects.
 
Treatment
Tetracycline, erythromycin.
Vaccine
None currently available.

mycoplasma pneumonia

Primary atypical pneumonia; walking pneumonia Infectious disease A primary atypical pneumonia by M pneumoniae, which causes miniepidemics that spread by aerosol or close contact, causing up to34 of a 'closed population'–military 'boot' camps, boarding schools, colleges–pneumonias, affecting ages 5-20 Clinical Incubation ± 3 wks; insidious onset of fever, malaise, headache, myalgia, low-grade fever, cough, chest pain, and respiratory disease from asymptomatic to rhinitis, pharyngitis, tracheobronchitis, pneumonia Lab Leukocytosis, relative ↑ in PMNs, cold hemagglutinins, biologic false positive VDRL Complications Erythema multiforme, Raynaud's phenomenon, cold agglutinin hemolysis; less commonly, neurologic, cardiovascular, musculoskeletal defects Treatment Tetracycline, erythromycin Vaccine Under development

Mycoplasma pneumonia

An incomplete bacterium that infects the lung.Mentioned in: Erythema Multiforme